Jan. 23, 2020 Price forecast | 2 weeks: -1.14% | 1 month: -1.83% | 3 months: -4.27%


PTCT stock forecast

Our latest prediction for PTC Therapeutics, Inc.'s stock price was made on the Jan. 23, 2020 when the stock price was at 53.33$.

In the short term (2weeks), PTCT's stock price should underperform the market by -1.14%. During that period the price should oscillate between -8.60% and +6.12%.

In the medium term (3months), PTCT's stock price should underperform the market by -4.27%. During that period the price should oscillate between -29.19% and +15.20%.


About PTC Therapeutics, Inc.

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

At the moment the company generates 297M USD in revenues.

On its last earning announcement, the company reported a loss of -4.00$ per share.

The book value per share is 5.33$

PTC Therapeutics, Inc. website


Three months stock forecastJan. 23, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
297M 95.80% -158M -53.30% -222M -4.00 - - 56M 5.33 -104M -38M -142M